Brachytherapy: Increased Use in Patients With Intermediate- and High-Risk Prostate Cancers

Background: Brachytherapy is a well-established and effective primary treatment modality for low- and favorable intermediate–risk prostate cancers. Although the benefits of brachytherapy in unfavorable intermediate– and high-risk prostate cancers have not been as clear, research suggests that brachytherapy boost may improve biochemical progression-free survival in these patients.

Objectives: This article aims to discuss evidence for the revival of brachytherapy use in unfavorable intermediate– and high-risk prostate cancers and specific nursing implications in the management of these patients.

Methods: The literature on brachytherapy and its use to treat localized prostate cancers was reviewed.

Findings: Nurses should be knowledgeable about the indications for brachytherapy, patient eligibility, anticipated side effects, and symptom management.